To date, the recommended first-line therapy for adult ITP patients is corticosteroids or intravenous immunoglobulin (IVIG), while monoclonal antibody treatment or thrombopoietin (TPO) receptor agonist (TPO-RA) has been used as a second-line therapy [2]. Here, TPO is linked to autoimmune thrombocytopenic purpura.